Patents by Inventor Silke Møller Larsen

Silke Møller Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable formulation of modified GLP-1
    Patent number: 8846618
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: September 30, 2014
    Assignee: Novo Nordisk A/S
    Inventors: James M. Flink, Silke Møller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund
  • Pharmaceutical formulation
    Patent number: 8841252
    Abstract: The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: September 23, 2014
    Assignee: Novo Nordisk Health Care AG
    Inventors: Søren Bjørn, Hans Holmegaard Sørensen, Peter Langballe, Silke Møller Larsen, Kristen Ebbehøj, Birthe Lykkegaard Hansen
  • STABLE FORMULATION OF MODIFIED GLP-1
    Publication number: 20100234299
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 16, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: JAMES M. FLINK, SILKE MØLLER LARSEN, SIMON BJERREGAARD JENSEN, DORTHE KOT ENGELUND
  • Pharmaceutical Formulation
    Publication number: 20100029569
    Abstract: The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.
    Type: Application
    Filed: October 8, 2009
    Publication date: February 4, 2010
    Applicant: Novo Nordisk Healthcare AG
    Inventors: Søren Bjørn, Hans Holmegaard Sørensen, Peter Langballe, Silke Møller Larsen, Kirsten Ebbehøj, Birthe Lykkegaard Hansen